{"count": 7, "results": [{"_id": "36166186", "pmid": 36166186, "title": "Relationship Between Calcium Channel Blockers Therapy and Cognitive Function Improvement in Cognitive Decline Patients with Cerebrovascular Disease.", "journal": "High Blood Press Cardiovasc Prev", "authors": ["Jeong HT", "Sung HH", "Lee JH", "Park KY", "Youn YC"], "date": "2022-11-01T00:00:00Z", "doi": "10.1007/s40292-022-00538-1", "meta_date_publication": "2022 Nov", "meta_volume": "29", "meta_issue": "6", "meta_pages": "595-600", "score": 50266.72, "text_hl": "AIM: This study aimed to evaluate the effect of 24 weeks of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@S-amlodipine besylate@@@ therapy on cognitive function in @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular disease@@@. ", "citations": {"NLM": "Jeong HT, Sung HH, Lee JH, Park KY, Youn YC. Relationship Between Calcium Channel Blockers Therapy and Cognitive Function Improvement in Cognitive Decline Patients with Cerebrovascular Disease. High Blood Press Cardiovasc Prev. 2022 Nov;29(6):595-600. PMID: 36166186", "BibTeX": "@article{36166186, title={Relationship Between Calcium Channel Blockers Therapy and Cognitive Function Improvement in Cognitive Decline Patients with Cerebrovascular Disease.}, author={Jeong HT and Sung HH and Lee JH and Park KY and Youn YC}, journal={High Blood Press Cardiovasc Prev}, volume={29}, number={6}, pages={595-600}}"}}, {"_id": "36859481", "pmid": 36859481, "pmcid": "PMC9977931", "title": "Effect of long-term antihypertensive treatment on cerebrovascular structure and function in hypertensive rats", "journal": "Sci Rep", "authors": ["Naessens DMP", "de Vos J", "Richard E", "Wilhelmus MMM", "Jongenelen CAM", "Scholl ER", "van der Wel NN", "Heijst JA", "Teunissen CE", "Strijkers GJ", "Coolen BF", "VanBavel E", "Bakker ENTP"], "date": "2023-03-01T00:00:00Z", "doi": "10.1038/s41598-023-30515-0", "meta_date_publication": "2023 Mar 1", "meta_volume": "13", "meta_issue": "1", "meta_pages": "3481", "score": 50246.246, "text_hl": "Both drugs lowered blood pressure equally, while only @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@ decreased heart rate. @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@Cerebrovascular resistance@@@ was increased in SHR, which was prevented by @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ but not @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@. ", "citations": {"NLM": "Naessens DMP, de Vos J, Richard E, Wilhelmus MMM, Jongenelen CAM, Scholl ER, van der Wel NN, Heijst JA, Teunissen CE, Strijkers GJ, Coolen BF, VanBavel E, Bakker ENTP. Effect of long-term antihypertensive treatment on cerebrovascular structure and function in hypertensive rats Sci Rep. 2023 Mar 1;13(1):3481. PMID: 36859481", "BibTeX": "@article{36859481, title={Effect of long-term antihypertensive treatment on cerebrovascular structure and function in hypertensive rats}, author={Naessens DMP and de Vos J and Richard E and Wilhelmus MMM and Jongenelen CAM and Scholl ER and van der Wel NN and Heijst JA and Teunissen CE and Strijkers GJ and Coolen BF and VanBavel E and Bakker ENTP}, journal={Sci Rep}, volume={13}, number={1}, pages={3481}}"}}, {"_id": "24389820", "pmid": 24389820, "title": "Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats.", "journal": "J Pharmacol Sci", "authors": ["Okamura T", "Tawa M", "Geddawy A", "Shimosato T", "Iwasaki H", "Shintaku H", "Yoshida Y", "Masada M", "Shinozaki K", "Imamura T"], "date": "2014-01-01T00:00:00Z", "doi": "10.1254/jphs.13178fp", "meta_date_publication": "2014", "meta_volume": "124", "meta_issue": "1", "meta_pages": "76-85", "score": 50072.02, "text_hl": "Effects of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, and their combination on @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@vascular dysfunction@@@ in insulin-resistant @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Okamura T, Tawa M, Geddawy A, Shimosato T, Iwasaki H, Shintaku H, Yoshida Y, Masada M, Shinozaki K, Imamura T. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats. J Pharmacol Sci. 2014;124(1):76-85. PMID: 24389820", "BibTeX": "@article{24389820, title={Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats.}, author={Okamura T and Tawa M and Geddawy A and Shimosato T and Iwasaki H and Shintaku H and Yoshida Y and Masada M and Shinozaki K and Imamura T}, journal={J Pharmacol Sci}, volume={124}, number={1}, pages={76-85}}"}}, {"_id": "23443495", "pmid": 23443495, "title": "Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats.", "journal": "Naunyn Schmiedebergs Arch Pharmacol", "authors": ["Mollnau H", "Oelze M", "Zinßius E", "Hausding M", "Wu Z", "Knorr M", "Ghaemi Kerahrodi J", "Kröller-Schön S", "Jansen T", "Teutsch C", "Foster C", "Li H", "Wenzel P", "Schulz E", "Münzel T", "Daiber A"], "date": "2013-05-01T00:00:00Z", "doi": "10.1007/s00210-013-0842-7", "meta_date_publication": "2013 May", "meta_volume": "386", "meta_issue": "5", "meta_pages": "405-19", "score": 50068.98, "text_hl": "Effects of @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@ or @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ monotherapy versus @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ combination therapy on @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@vascular dysfunction@@@ and oxidative stress in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Mollnau H, Oelze M, Zinßius E, Hausding M, Wu Z, Knorr M, Ghaemi Kerahrodi J, Kröller-Schön S, Jansen T, Teutsch C, Foster C, Li H, Wenzel P, Schulz E, Münzel T, Daiber A. Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats. Naunyn Schmiedebergs Arch Pharmacol. 2013 May;386(5):405-19. PMID: 23443495", "BibTeX": "@article{23443495, title={Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats.}, author={Mollnau H and Oelze M and Zinßius E and Hausding M and Wu Z and Knorr M and Ghaemi Kerahrodi J and Kröller-Schön S and Jansen T and Teutsch C and Foster C and Li H and Wenzel P and Schulz E and Münzel T and Daiber A}, journal={Naunyn Schmiedebergs Arch Pharmacol}, volume={386}, number={5}, pages={405-19}}"}}, {"_id": "12122965", "pmid": 12122965, "title": "The effects of amlodipine on cerebral circulatory values in patients with essential hypertension.", "journal": "Anadolu Kardiyol Derg", "authors": ["Alizade IG", "Karayeva NT"], "date": "2001-03-01T00:00:00Z", "meta_date_publication": "2001 Mar", "meta_volume": "1", "meta_issue": "1", "meta_pages": "14-6", "score": 50059.04, "text_hl": "@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ along with the reduction in systemic blood pressure caused attenuation of @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular abnormalities@@@: decrease in @DISEASE_Muscle_Spasticity @DISEASE_MESH:D009128 @@@spastic@@@ signs and increase in cerebral blood supply in @SPECIES_9606 @@@patients@@@ with @DISEASE_Essential_Hypertension @DISEASE_MESH:D000075222 @@@essential hypertension@@@. ", "citations": {"NLM": "Alizade IG, Karayeva NT. The effects of amlodipine on cerebral circulatory values in patients with essential hypertension. Anadolu Kardiyol Derg. 2001 Mar;1(1):14-6. PMID: 12122965", "BibTeX": "@article{12122965, title={The effects of amlodipine on cerebral circulatory values in patients with essential hypertension.}, author={Alizade IG and Karayeva NT}, journal={Anadolu Kardiyol Derg}, volume={1}, number={1}, pages={14-6}}"}}, {"_id": "19687579", "pmid": 19687579, "title": "Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease.", "journal": "Intern Med", "authors": ["Takei K", "Araki N", "Ohkubo T", "Tamura N", "Yamamoto T", "Furuya D", "Yanagisawa CT", "Shimazu K"], "date": "2009-01-01T00:00:00Z", "doi": "10.2169/internalmedicine.48.2158", "meta_date_publication": "2009", "meta_volume": "48", "meta_issue": "16", "meta_pages": "1357-61", "score": 50058.754, "text_hl": "In the @CHEMICAL_cilnidipine @CHEMICAL_MESH:C065927 @@@cilnidipine@@@ groups, no difference in average 24-hour or waking systolic blood pressure values was seen between @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular disease@@@ (@<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@CVD@@@) subjects and non-@<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@CVD@@@ subjects, although in the @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ groups, @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@CVD@@@ subjects had significantly higher blood pressure values than non-@<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@CVD@@@ subjects. ", "citations": {"NLM": "Takei K, Araki N, Ohkubo T, Tamura N, Yamamoto T, Furuya D, Yanagisawa CT, Shimazu K. Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease. Intern Med. 2009;48(16):1357-61. PMID: 19687579", "BibTeX": "@article{19687579, title={Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease.}, author={Takei K and Araki N and Ohkubo T and Tamura N and Yamamoto T and Furuya D and Yanagisawa CT and Shimazu K}, journal={Intern Med}, volume={48}, number={16}, pages={1357-61}}"}}, {"_id": "22089534", "pmid": 22089534, "title": "Optimal Combination of Effective ANtihypertensives (OCEAN) study: a prospective, randomized, open-label, blinded endpoint trial--rationale, design and results of a pilot study in Japan.", "journal": "Hypertens Res", "authors": ["Kageyama S", "Ueda S", "Mochizuki K", "Miyakawa M", "Sugawara M", "Nakayama M", "Ohashi Y", "Saito I", "Saruta T", "OCEAN Study Group"], "date": "2012-02-01T00:00:00Z", "doi": "10.1038/hr.2011.178", "meta_date_publication": "2012 Feb", "meta_volume": "35", "meta_issue": "2", "meta_pages": "221-7", "score": 50042.547, "text_hl": "Two hundred and sixty-six @SPECIES_9606 @@@patients@@@ (mean age: 65.9 years) were treated with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ alone. One hundred and fifty-four of these @SPECIES_9606 @@@patients@@@ (57.9%) did not reach the treatment targets (<140/90 mm Hg for the elderly and @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular disease@@@, <130/80 mm Hg for those with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@, @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@chronic kidney disease@@@ or prior @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@) and a second agent was added. ", "citations": {"NLM": "Kageyama S, Ueda S, Mochizuki K, Miyakawa M, Sugawara M, Nakayama M, Ohashi Y, Saito I, Saruta T, OCEAN Study Group. Optimal Combination of Effective ANtihypertensives (OCEAN) study: a prospective, randomized, open-label, blinded endpoint trial--rationale, design and results of a pilot study in Japan. Hypertens Res. 2012 Feb;35(2):221-7. PMID: 22089534", "BibTeX": "@article{22089534, title={Optimal Combination of Effective ANtihypertensives (OCEAN) study: a prospective, randomized, open-label, blinded endpoint trial--rationale, design and results of a pilot study in Japan.}, author={Kageyama S and Ueda S and Mochizuki K and Miyakawa M and Sugawara M and Nakayama M and Ohashi Y and Saito I and Saruta T and OCEAN Study Group}, journal={Hypertens Res}, volume={35}, number={2}, pages={221-7}}"}}]}